Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Expleo SolutionsNSE:EXPLEOSOL +1.07%90 Days Sales Outstanding is 71.85 as of Jun. 2026, which is 8% below its 10-year median of 78.41. GuruFocus rates NSE:EXPLEOSOL with a GF Score™ of 90/100 and a GF Value™ of ₹1,249.61 (Significantly Undervalued). The stock has 3 warning signs investors should review. Among 2,773 Software companies, Expleo Solutions ranks worse than 64.44% on this metric.
The historical rank and industry rank for Expleo Solutions's Days Sales Outstanding or its related term are showing as below:
NSE:EXPLEOSOL'
s Days Sales Outstanding Range Over the Past 10 Years
Min: 57.63 Med: 78.41 Max: 92.45
Current: 74.8
During the past 13 years, Expleo Solutions's highest Days Sales Outstanding was 92.45. The lowest was 57.63. And the median was 78.41.
NSE:EXPLEOSOL's Days Sales Outstanding is ranked worse than 64.44% of 2773
companies
in the Software industry
Industry Median: 60.38
vs NSE:EXPLEOSOL: 74.80
Expleo Solutions's Days Sales Outstanding
declined
from Jun. 2025 (78.13) to Jun. 2026 (71.85).
Expleo Solutions (NSE:EXPLEOSOL) Days Sales Outstanding Explanation
For retailers, when we compare Days Sales Outstanding, it is important to compare the same period in the previous years.
Expleo Solutions Days Sales Outstanding Related Terms
Expleo Solutions Days Sales Outstanding Historical Data
* Premium members only.
The historical data trend for Expleo Solutions's Days Sales Outstanding can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
NSE:EXPLEOSOL vs IBM, ACN, FISV: Days Sales Outstanding Comparison
For the Information Technology Services subindustry, Expleo Solutions's Days Sales Outstanding, along with its competitors' market caps and Days Sales Outstanding data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Expleo Solutions Days Sales Outstanding vs Software Industry
For the Software industry and Technology sector, Expleo Solutions's Days Sales Outstanding distribution charts can be found below:
* The bar in red indicates where Expleo Solutions's Days Sales Outstanding falls into.
Expleo Solutions Days Sales Outstanding Calculation
Days Sales Outstanding measures the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Expleo Solutions (NSE:EXPLEOSOL) has a Days Sales Outstanding of 71.85 as of Jun. 2026. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Expleo Solutions and its competitors. This is near median its historical median of 78.41. Over the past decade, Expleo Solutions' Days Sales Outstanding has ranged from 57.63 to 92.45. According to the industry distribution chart, Expleo Solutions ranks #1787 out of 2773 companies in the Software industry, placing it in the top 64.4%.
Is Expleo Solutions' Days Sales Outstanding too high?
Expleo Solutions' current Days Sales Outstanding of 71.85 is near median its 10-year median of 78.41. Over the past 10 years, this metric has ranged from a low of 57.63 to a high of 92.45. The Software industry median Days Sales Outstanding is 60.38. Expleo Solutions' value of 71.85 is 19% above this industry median. Based on the distribution chart, Expleo Solutions ranks #1787 out of 2773 companies in the Software industry, which is below the industry midpoint. Overall, Expleo Solutions has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Expleo Solutions' Days Sales Outstanding compare to IBM and ACN?
According to the Software industry distribution chart, Expleo Solutions ranks #1787 out of 2773 companies for Days Sales Outstanding. This places Expleo Solutions in the lower half of its industry. The industry median Days Sales Outstanding is 60.38. Expleo Solutions' value of 71.85 is 19% above this benchmark. Historically, Expleo Solutions' own Days Sales Outstanding has ranged from 57.63 to 92.45 over the past decade. While the company's 10-year median is 78.41 vs. the industry median of 60.38, Expleo Solutions has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Sales Outstanding for a Software company?
The median Days Sales Outstanding among Software companies is 60.38, based on 2,773 companies in the industry. Companies in the top quartile (top 25%) have a Days Sales Outstanding significantly above this median, while those in the bottom quartile fall well below. However, Days Sales Outstanding should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Expleo Solutions's current Days Sales Outstanding of 71.85 is 19% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Sales Outstanding mean?
A high Days Sales Outstanding can signal that a stock is expensive relative to its fundamentals. Days sales outstanding represents the average amount of days a company takes to collect receivables. View historical data on Expleo Solutions and its competitors. For the Software industry, the median Days Sales Outstanding is 60.38 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Expleo Solutions's current Days Sales Outstanding is 71.85, which is near median its own 10-year median of 78.41. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Expleo Solutions stock overvalued right now?
Based on GuruFocus' analysis, Expleo Solutions (NSE:EXPLEOSOL) is currently considered Significantly Undervalued. The stock's GF Value™ is ₹1,249.61, compared to a current price of ₹879.95 — trading 29.6% below its estimated fair value. The current Days Sales Outstanding is 71.85, which is near median its 10-year median of 78.41 and 19% above the Software industry median of 60.38. Expleo Solutions' overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Sales Outstanding calculated?
Days Sales Outstanding is calculated from a company's financial statements. For Expleo Solutions (NSE:EXPLEOSOL), the current Days Sales Outstanding is 71.85 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Expleo Solutions (NSE:EXPLEOSOL) Overvalued in 2026?
Based on GuruFocus' analysis, Expleo Solutions stock appears to be undervalued.
The current stock price of ₹879.95 is trading 29.6% below its estimated GF Value™ of ₹1,249.61.
GuruFocus considers Expleo Solutions to be Significantly Undervalued.
Key valuation signals for NSE:EXPLEOSOL:
Days Sales Outstanding: 71.85 (near median its 10-year median of 78.41)
GF Value™: ₹1,249.61 vs. price of ₹879.95 (29.6% below fair value)
Industry Position: 19% above the Software median (#1787 of 2773)
No single metric tells the full story. See the NSE:EXPLEOSOL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Expleo Solutions Ltd is an India-based holding company. It is engaged in providing software testing services. The company delivers software validation and verification services to the banking and financial services industry around the world. It offers its services to various industries, including banking, finance, and insurance; energy and utilities; automotive and manufacturing; retail and logistics, and telecommunications. The services offered by the company consist of Management Consultancy, Quality Management, Technical Testing Services and Training services.
90GF Score
Get the complete analysis for NSE:EXPLEOSOL
Days Sales Outstanding is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:EXPLEOSOL has been successfully added to your 
